Ibuphil Cold

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibuphil Cold

Quick Facts

Property Description
Active ingredient Ibuprofen, Pseudoephedrine
Form Oral preparation (Tablet or capsule)
Pharmacological class Analgesic, Antipyretic, Anti-inflammatory, Decongestant
Common use Multisymptom relief for cold and flu discomfort
Origin Synthetic

What Type of Medicine is Ibuphil Cold?

Ibuphil Cold is a synthetic, fixed-dose combination product intended for oral administration, combining two distinct pharmaceutical agents into one solid preparation. It is classified pharmacologically as a dual-action medicine, encompassing the properties of an analgesic, antipyretic, anti-inflammatory, and decongestant agent, targeting the combined symptoms of colds and flu. The fixed combination of Ibuprofen and Pseudoephedrine is intended to provide relief for multiple cold symptoms compared to the use of either ingredient alone.

Composition: Ibuprofen and Pseudoephedrine

The core of Ibuphil Cold is its two active ingredients: Ibuprofen and Pseudoephedrine. Ibuprofen is formally categorized as a Nonsteroidal Anti-Inflammatory Drug (NSAID), which acts systemically to reduce pain and inflammation throughout the body. Pseudoephedrine is a sympathomimetic amine, specifically included for its decongestant properties, which target the blood vessels in the nasal passages. The medicine is typically delivered as a solid oral preparation, such as a tablet or capsule, formulated with standard solid pharmaceutical excipients.

Differentiating Features and General Purpose

Ibuphil Cold is distinguished by its direct focus on simultaneously addressing both pain/fever and congestion in adult and adolescent patient groups, positioning it as a dedicated multisymptom treatment for upper respiratory symptoms. This specific fixed-dose combination of Ibuprofen and Pseudoephedrine is recognized for its reliable efficacy in managing the core discomfort of a heavy cold or flu-like illness. A typical use scenario involves relief from the combination of a throbbing headache, fever, and a blocked or congested nose. This approach efficiently addresses systemic discomfort and localized congestion without requiring the use of two separate medications.

Regulatory References

  1. NIH PubMed Search: Ibuprofen/Pseudoephedrine Cold Efficacy

What side effects are possible with Ibuphil Cold?

Possible side effects and safety information

This section outlines the officially documented safety profile and adverse reactions for Ibuphil Cold, based on government regulatory labeling for the combination of Ibuprofen and Pseudoephedrine.

Serious Safety Warnings and Contraindications

The medicine's regulatory label includes serious warnings regarding the potential for major cardiovascular thrombotic events (such as heart attack or stroke), which can be fatal. This risk may increase with longer use and higher doses. Another major warning concerns serious gastrointestinal side effects, including bleeding, ulceration, and perforation of the stomach or intestines, which may also be fatal.

Contraindications define absolute restrictions on use, including patients with a history of severe allergic reactions to NSAIDs (like aspirin-sensitive asthma), those who have recently had heart bypass graft surgery (CABG), or patients taking Monoamine Oxidase Inhibitors (MAOIs).

Common and Clinically Significant Adverse Reactions

Commonly reported side effects include gastrointestinal disturbances (heartburn, nausea, stomach pain) and central nervous system effects (headache, dizziness, and difficulty sleeping due to the stimulant component).

Less common but clinically significant reactions include severe skin reactions (like Stevens-Johnson Syndrome), anaphylaxis, liver injury (hepatotoxicity), and fluid retention that can worsen high blood pressure or heart failure.

Population-Specific Restrictions

Use is generally restricted in the elderly due to an increased risk of serious GI and cardiovascular events, necessitating the use of the lowest effective dose for the shortest duration. The medicine is also restricted or avoided in the last trimester of pregnancy.

This information represents the formal regulatory safety framework and is not a guide for clinical management or dosing.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Official regulatory documentation states that an overdose of Ibuphil Cold may present with symptoms linked to both active components. Manifestations may include gastrointestinal disturbances such as nausea, vomiting, or abdominal pain, alongside central nervous system (CNS) effects, including drowsiness, headache, and tinnitus. Due to the Pseudoephedrine component, agitation, restlessness, tremor, and tachycardia are also recognized clinical signs.

Overdose is officially classified as potentially severe or life-threatening. Documented serious outcomes include significant CNS depression leading to coma or seizures, severe cardiovascular events such as hypertensive crisis and cardiac arrhythmias, and acute organ damage, notably acute kidney injury.

Required Emergency Actions

Any suspected ingestion of Ibuphil Cold exceeding the recommended dose requires immediate medical attention. Regulatory authorities mandate that a Poison Control Center or emergency services must be contacted right away, particularly if symptoms of severe toxicity, like loss of consciousness, trouble breathing, or a sudden, severe headache, occur.

Treatment is defined as symptomatic and supportive, as no specific antidote is known for this combination product. Management procedures documented in official labels may include gastric decontamination measures, such as administration of activated charcoal, and monitoring of renal function and cardiac stability.

Therapeutic Uses of Ibuphil Cold

What Ibuphil Cold Treats: Main Uses and Benefits

Ibuphil Cold is commonly used to provide symptomatic relief in contexts where short-term symptom management is appropriate, addressing symptoms related to acute physical discomfort and systemic imbalance. This combination product is intended to temporarily relieve symptoms associated with the common cold or flu, covering both pain/fever and congestion.

This medication is applied in addressing key symptom clusters that include headache, minor body aches, elevated fever, stuffy nose, nasal congestion, and sinus pressure. It is commonly used across conditions presenting with acute episodes, such as the common cold or flu, when these symptoms cluster together.

“It helps manage the groups of symptoms that may become intense or disruptive and create noticeable functional strain.”

By easing these manifestations, the medication contributes to improved comfort and supports patients during difficult episodes by easing distress. It is relevant in clinical settings that involve acute symptom patterns, where additional management of discomfort is required, and helps support general well-being.

Quick Fact: Relevant for Symptom Clusters (Pain, Fever, and Congestion)

Regulatory References

  1. DailyMed confirms that this combination product is intended to temporarily relieve symptoms associated with the common cold or flu

Eligibility and Restrictions for Use

Who Can and Cannot Use Ibuphil Cold?

Ibuphil Cold is a combination medication containing ibuprofen (a nonsteroidal anti-inflammatory drug or NSAID) and phenylephrine (a decongestant). Its use is appropriate for most adults and children over 12 years of age seeking temporary relief from common cold symptoms, such as fever, headache, body aches, sinus congestion, and nasal stuffiness.


However, due to the active ingredients, certain individuals should not take Ibuphil Cold. This includes:

  • Children under 12 years of age.
  • Individuals with a known allergy to ibuprofen, phenylephrine, or other NSAIDs (like aspirin).
  • Those with severe heart conditions (e.g., severe heart failure, uncontrolled high blood pressure) or stroke history, as phenylephrine can affect blood pressure and heart rate.
  • People with active stomach ulcers or a history of severe gastrointestinal bleeding caused by NSAIDs.
  • Individuals currently taking Monoamine Oxidase Inhibitors (MAOIs), or within 14 days of stopping an MAOI, as this combination can cause a dangerous increase in blood pressure (hypertensive crisis).

Additionally, caution and consultation with a healthcare provider are necessary for those with asthma, kidney or liver disease, diabetes, thyroid disorders, or glaucoma before use.

What should I know about interactions with other medicines?

Ibuphil Cold Interactions with Other Medicines and Products

This section outlines the officially documented interaction profile for Ibuphil Cold, a combination of Ibuprofen and Pseudoephedrine, based strictly on government regulatory documents.

Formal Contraindicated Combinations

Co-administration of Ibuphil Cold is prohibited under specific circumstances:

  • Monoamine Oxidase Inhibitors (MAOIs): The medicine must not be used concurrently with, or within two weeks of stopping, an MAOI due to the risk of severe effects.
  • Coronary Artery Bypass Graft (CABG) Surgery: Use is contraindicated immediately before or after heart bypass surgery.

Documented Drug-Drug Interactions

Interacting Substance/Class Official Interaction Description
Other NSAIDs / Aspirin Increased risk of gastrointestinal bleeding and other adverse effects; Ibuprofen may interfere with the cardioprotective effect of low-dose aspirin.
Anticoagulants / Corticosteroids Increased risk of bleeding, especially gastrointestinal hemorrhage.
Lithium / Methotrexate Ibuprofen can reduce the renal clearance of Lithium and the tubular secretion of Methotrexate, which may lead to increased exposure of these medicines.
Diuretics / Antihypertensives Ibuprofen is documented to reduce the blood pressure-lowering and fluid-clearing effects of these agents.
Other Sympathomimetics Co-administration may enhance cardiovascular and Central Nervous System (CNS) effects.

Non-Medicine and Population Constraints

  • Alcohol: The risk of severe stomach bleeding is noted to be increased with the consumption of three or more alcoholic drinks daily while using this product.
  • Elderly Patients: Individuals aged 60 years or older are cited in official labeling as having a higher potential for severe stomach bleeding, particularly when combined with anticoagulants or corticosteroids.

Mechanism of Action

Modulation of Prostaglandin Synthesis and Thermoregulation

The component Ibuprofen non-selectively inhibits the Cyclooxygenase (COX) enzymes, which are responsible for generating prostaglandins—key local mediators involved in nociception and thermoregulation. This action modulates the elevated set-point in the hypothalamus and limits peripheral nociceptor sensitization, resulting in the attenuation of systemic pain and hyperthermic signals.


Local alpha-Adrenergic Receptor Vasoconstriction

The component Pseudoephedrine acts as a sympathomimetic, stimulating alpha-adrenergic receptors (alpha-adrenoceptors) in the blood vessels of the nasal mucosa, largely by triggering the release of norepinephrine. This interaction initiates a signaling sequence that causes localized vasoconstriction (vessel narrowing), which limits blood flow and fluid leakage, thereby directly reducing localized fluid volume and tissue engorgement.


Distinct Mechanistic Pathways

The two components operate through distinct mechanistic pathways, simultaneously addressing systemic inflammatory signaling and localized adrenergic-driven vascular responses. This combination results in simultaneous modulation across two distinct physiological systems, establishing the drug's overall dual mechanism.

Dosage and Administration Information

How to Use Ibuphil Cold

Ibuphil Cold is an oral preparation intended for short-term symptomatic use, with established guidelines to control the total exposure to its active ingredients. The usage principles detail the route, dosage limits, frequency, and duration of self-treatment for adults and adolescents.


Official Administration Guidelines

The medicine is designed for systemic absorption via swallowing and is available for the oral route using solid forms, such as tablets or caplets.

Instruction
Dosing Schedule The standard single dose is 1 to 2 tablets/caplets (200 mg Ibuprofen / 30 mg Pseudoephedrine up to 400 mg / 60 mg).
Frequency and Interval Doses are typically taken every 4 to 6 hours as needed. A minimum interval of 4 hours is required between administrations.
Maximum Daily Limit The total intake must not exceed 6 tablets/caplets (1200 mg Ibuprofen / 180 mg Pseudoephedrine) in a 24-hour period.
Context of Intake The dose should be swallowed whole with water. It may be taken with food or milk to potentially mitigate gastrointestinal discomfort.
Duration of Use Use is limited to short-term management, with many labels specifying a maximum self-treatment duration of 5 to 7 days in total.

Population-Specific Rules

Ibuphil Cold is officially labeled for use in Adults and adolescents 12 years of age and over. The product should not be used in children under 12 years of age. For older adults (geriatric patients), the general principle applies that the smallest effective dose should be used for the shortest duration necessary to control symptoms.

Recent Clinical Evidence

Overview of Studies for Ibuphil Cold

Evidence for Symptom Management in Colds and Flu

The research evidence explores patterns in conditions characterized by fluctuating or episodic manifestations, such as the common cold or flu-like illness. The evidence landscape for this combination product includes multiple short-term Randomized Controlled Trials (RCTs). Studies were designed to monitor symptom intensity and variability over defined time intervals.

Researchers have examined various patient-reported outcomes describing perceived discomfort, including outcomes related to systemic or functional imbalance. Studies monitor changes in pain-related symptoms (like headache and body aches) and congestion-related symptoms (like stuffy nose or sinus pressure) during periods of heightened symptom activity. Trials reported measurements of Total Symptom Scores and examined whether different patterns of symptom change were observed when comparing the combination product to a placebo or to taking only one of the active ingredients alone. Evidence contributes to the broader evidence landscape by detailing how the combination was studied for outcomes related to physical discomfort during acute cold and flu episodes.

Studies on Formulation and Drug Delivery

In addition to clinical symptom studies, other research has examined the physical properties of the combined product itself. These Pharmacokinetic (PK) and Bioequivalence Studies involve healthy volunteers and are focused on describing how the two active ingredients are absorbed into the bloodstream.

Research Gaps and Population Limitations

The research exploring how symptoms change over time is typically short-term. Follow-up durations in the primary efficacy studies were limited to the expected course of the acute illness. Long-term effects are not well characterized because research focused on short-term periods. Data for certain groups, including children under the age of 12 and patients with complex, underlying health conditions (comorbidities), remain insufficient. The available evidence contributes to the broader evidence landscape; however, there may be some variability across studies in terms of reported outcomes. The results apply only to the populations studied and research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Ibuphil Cold (FAQ)


Q: Is Ibuphil Cold the same as regular Ibuprofen?

Official documentation describes Ibuphil Cold as a fixed-dose combination product. It contains Ibuprofen (a Nonsteroidal Anti-Inflammatory Drug or NSAID) and Pseudoephedrine (a decongestant). Regular Ibuprofen, in contrast, typically contains only the NSAID component.

Q: Can I take Ibuphil Cold if I only have a headache?

According to the official product information, Ibuphil Cold is indicated for the temporary relief of symptoms associated with the common cold or flu. This constellation of symptoms specifically includes headache and fever relief alongside congestion.

Q: Does Ibuphil Cold make you feel sleepy?

Regulatory information cites potential Central Nervous System (CNS) side effects that include trouble sleeping or nervousness due to the decongestant component. Some clinical reports also include dizziness or drowsiness, so individuals may experience varied effects.

Q: Are there any common foods or drinks that interact with Ibuphil Cold?

Official warnings advise that the risk of severe stomach bleeding is increased with the consumption of three or more alcoholic drinks daily while using the product. No other specific common foods or drinks are specifically noted in the regulatory warnings regarding interactions.

Q: What is the difference between Ibuphil Cold and a decongestant-only medicine?

Ibuphil Cold is a fixed-dose combination product that targets two categories of symptoms simultaneously. It contains Ibuprofen for pain and fever, and Pseudoephedrine for congestion. A decongestant-only medicine only addresses the congestion component.

Q: How long does the effect of Ibuphil Cold usually last?

The recommended dosing frequency for Ibuphil Cold is typically every 4 to 6 hours. This interval is specified in official guidance as the recommended frequency for use to maintain symptomatic relief.

Q: Does the medicine come in different strengths or formulations?

The product is typically available without prescription in a standard, fixed strength of the active ingredients. Official guidance notes that a single dose for adults may consist of one or two units (tablets or caplets) to adjust the total dose taken.

Q: Do researchers know exactly why Ibuphil Cold helps with cold symptoms?

Regulatory science provides a detailed explanation of the mechanism of action. Ibuprofen works systemically to reduce pain and fever by modulating chemical signals in the body, while Pseudoephedrine works locally to relieve nasal congestion by narrowing blood vessels in the nose.

Q: Can Ibuphil Cold interact with commonly used herbal supplements?

Official documentation includes a general recommendation to consult a healthcare professional or pharmacist before use if taking any other drug. This general caution is often applied to the use of all non-prescribed medicines, including herbal or dietary supplements.

Q: Does Ibuphil Cold contain acetaminophen (paracetamol)?

The active ingredients in Ibuphil Cold are explicitly listed as Ibuprofen and Pseudoephedrine. Official labeling does not list Acetaminophen (Paracetamol) as an ingredient in this fixed combination product.

Q: What does 'contraindication' mean in relation to Ibuphil Cold?

In the context of drug labeling, a contraindication describes a specific medical condition or circumstance where the medication is strictly prohibited from use. For Ibuphil Cold, examples include severe allergic reactions to NSAIDs or recent heart bypass surgery.

Q: Why might a person switch from a different cold medicine to Ibuphil Cold?

The product is officially described as a fixed-dose combination. This feature is described as addressing systemic discomfort and localized congestion simultaneously, without requiring the use of two separate medicines.

Q: Is Ibuphil Cold typically gluten-free or suitable for people with common allergies?

The label provides a specific Allergy Alert regarding the active ingredient Ibuprofen, particularly for those allergic to aspirin. For information regarding inactive ingredients like gluten or other excipients, patients are advised to read the product label or package ingredients carefully.

Q: What are the signs that Ibuphil Cold is working?

The expected effect of the medication, according to its official indications, is the temporary relief of the symptoms it is intended to treat. This includes a reduction in headache, body aches, fever, and nasal congestion.

Q: Does Ibuphil Cold contain caffeine or other stimulants?

The ingredient Pseudoephedrine is classified as a sympathomimetic amine, which is a class of stimulant. Due to this component, the label warns that common side effects can include nervousness and sleeplessness. Caffeine is not listed as an active ingredient.

Q: Does Ibuphil Cold thin the blood?

Regulatory information states that Ibuphil Cold, due to the Ibuprofen component, may increase the risk of bleeding when taken with certain blood-thinning (anticoagulant) medications. The drug is not classified as an anticoagulant itself.

Q: Can Ibuphil Cold cause changes in mood or anxiety levels?

The stimulant component, Pseudoephedrine, is associated with Central Nervous System (CNS) effects. Common side effects may include nervousness, restlessness, or being excited.

Q: How quickly does Ibuphil Cold start working?

Available data on the individual active ingredients suggests the decongestant component, Pseudoephedrine, can begin to work in approximately 30 minutes after ingestion. The full effect of the combination product is related to the absorption of both active components.

Q: Is it normal to feel a dry mouth after taking Ibuphil Cold?

Dry mouth is listed in authoritative drug information summaries as a potential side effect associated with the Pseudoephedrine component of the medicine.

Q: What happens if I forget to take Ibuphil Cold?

Official product guidance describes taking the dose as soon as it is remembered. If it is almost time for the next scheduled dose, the regulatory instruction is to skip the missed dose and resume the regular schedule. Official documents advise that two doses should not be taken at once.

Q: Can I use Ibuphil Cold if I'm already taking allergy medication?

Official documentation includes a warning against taking Ibuphil Cold with any other product that contains pseudoephedrine or any other nasal decongestant. General caution is advised when taking other medicines with potential overlaps.

Q: Are there specific symptoms that mean Ibuphil Cold is not suitable?

Regulatory information states that use should be stopped and a doctor consulted if signs of serious problems occur. Examples include symptoms of stomach bleeding (e.g., bloody stools or vomiting blood), symptoms of heart problems or stroke, or if a fever worsens or persists beyond the specified self-treatment duration.

Q: Is it possible to become dependent on Ibuphil Cold?

Regulatory reviews on the components generally note that the medicine does not carry an official risk of withdrawal phenomenon or addiction potential when used according to the directions on the label.

Q: What is the legal classification of Ibuphil Cold (e.g., over-the-counter)?

Regulatory classification confirms that Ibuphil Cold is authorized for sale as an Over-the-Counter (OTC) drug product in the United States and other regions. The classification authorizes consumer self-selection when used according to the label instructions.

Q: Why is Ibuphil Cold listed with potential kidney-related concerns?

Official warnings advise consultation with a doctor if the user has kidney disease. The Ibuprofen component, which is a type of NSAID, has known associations with kidney function and fluid retention.

Q: Does the official prescribing information mention any warnings about driving or operating machinery?

While official labels do not explicitly prohibit driving, they warn against common side effects such as dizziness and trouble sleeping (or nervousness). These effects may impair the ability to safely operate a vehicle or machinery.

Q: What should I do if I think I'm experiencing an uncommon side effect from Ibuphil Cold?

Patients are advised in official documentation to stop using the product and consult a healthcare professional if they experience serious or uncommon symptoms. Suspected side effects can also be reported to the relevant regulatory authority (e.g., FDA) through established safety programs.

Q: What is the meaning of 'off-label use' for Ibuphil Cold?

Off-label use is a regulatory term that refers to prescribing or using a medicine for a purpose, patient group, or dosage that is different from those specifically approved and listed on the official drug label by a government authority.

How should Ibuphil Cold be stored and disposed of?

How to Store and Dispose of Ibuphil Cold

Storage of this Ibuprofen/Pseudoephedrine combination product is defined by specific environmental controls required to maintain its stability and quality.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, between 20°C and 25°C (68°F and 77°F).
Protection Keep from freezing, excessive heat (above 40°C), moisture, and direct light.
Container Must be kept in a closed container.
Child Safety Mandatory instruction to keep out of the reach of children.

Disposal Instructions

Expired or unused medicine should be disposed of promptly. The preferred method is using a community drug take-back program. If a program is unavailable, the product may be mixed with an unappealing substance, placed into a sealed container, and disposed of in the household trash. Identifying information must be removed from the original container prior to discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibuphil Cold found in:

A-Z Index: